Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-07-08 Sale |
2022-07-12 7:39 pm |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | Anzalone Christopher Richard Chief Executive Officer |
551,197 | $0 | $0 | 3,508,938 (Direct) |
View |
| 2022-02-11 Sale |
2022-02-14 08:54 am |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | Anzalone Christopher Richard Chief Executive Officer |
146,388 | $51.91 | $7,598,864 | 4,672,667 (Direct) |
View |
| 2022-01-05 Sale |
2022-01-07 8:16 pm |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | O'Brien Patrick General Counsel |
32,500 | $61.72 | $2,005,875 | 348,075 (Direct) |
View |
| 2022-01-05 Sale |
2022-01-06 8:58 pm |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | Myszkowski Kenneth Allen Chief Financial Officer |
40,000 | $61.7 | $2,467,941 | 464,005 (Direct) |
View |
| 2022-01-04 Sale |
2022-01-06 8:56 pm |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | Hamilton James C Senior Vice President |
25,625 | $64.57 | $1,654,591 | 155,625 (Direct) |
View |
| 2022-01-03 Sale |
2022-01-04 9:35 pm |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | Waddill William D. Director |
4,500 | $64.72 | $291,244 | 25,750 (Direct) |
View |
| 2022-01-03 Sale |
2022-01-04 9:33 pm |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | OLUKOTUN ADEOYE Y Director |
4,050 | $64.75 | $262,233 | 4,950 (Direct) |
View |
| 2022-01-03 Sale |
2022-01-04 9:31 pm |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | De Backer Marianne Director |
4,500 | $64.71 | $291,177 | 17,000 (Direct) |
View |
| 2022-01-03 Sale |
2022-01-04 9:30 pm |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | PERRY MICHAEL S Director |
4,500 | $64.71 | $291,192 | 85,500 (Direct) |
View |
| 2021-12-28 Purchase |
2021-12-29 8:44 pm |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | GIVEN DOUGLAS B Director |
655 | $66.37 | $43,472 | 136,243 (Indirect Direct) |
View |
| 2021-12-28 Sale |
2021-12-29 8:41 pm |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | Ferrari Mauro Director |
3,400 | $66.82 | $227,188 | 36,571 (Direct) |
View |
| 2021-12-15 Sale |
2021-12-17 8:14 pm |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | Anzalone Christopher Richard Chief Executive Officer |
60,000 | $67.56 | $4,053,431 | 3,219,022 (Direct) |
View |
| 2021-11-19 Sale |
2021-11-22 4:56 pm |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | San Martin Javier Chief Medical Officer |
19,500 | $69.31 | $1,351,589 | 111,000 (Direct) |
View |
| 2021-10-20 Sale |
2021-10-22 5:58 pm |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | Anzalone Christopher Richard Chief Executive Officer |
65,000 | $65.77 | $4,274,982 | 3,279,022 (Direct) |
View |
| 2021-09-13 Sale |
2021-09-14 5:25 pm |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | OLUKOTUN ADEOYE Y Director |
5,000 | $63.76 | $318,800 | 9,000 (Direct) |
View |
| 2021-09-09 Sale |
2021-09-10 4:53 pm |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | GIVEN DOUGLAS B Director |
5,000 | $65.24 | $326,200 | 136,243 (Indirect Direct) |
View |
| 2021-06-24 Sale |
2021-06-25 6:59 pm |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | De Backer Marianne Director |
5,000 | $89.85 | $449,250 | 21,500 (Direct) |
View |
| 2021-06-22 Sale |
2021-06-24 6:44 pm |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | Hassard James Chief Commercial Officer |
3,625 | $89.22 | $323,423 | 105,750 (Direct) |
View |
| 2021-06-22 Sale |
2021-06-24 4:47 pm |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | GIVEN DOUGLAS B Director |
4,500 | $89.21 | $401,445 | 141,243 (Indirect Direct) |
View |
| 2021-02-22 Sale |
2021-02-24 6:51 pm |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | GIVEN DOUGLAS B Director |
1,125 | $88.73 | $99,821 | 145,743 (Indirect Direct) |
View |
| 2021-02-08 Sale |
2021-02-10 5:56 pm |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | O'Brien Patrick General Counsel |
90,000 | $88.46 | $7,961,240 | 353,375 (Direct) |
View |
| 2021-01-15 Sale |
2021-01-19 5:58 pm |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | GIVEN DOUGLAS B Director |
3,000 | $83.28 | $249,840 | 146,868 (Indirect Direct) |
View |
| 2021-01-14 Sale |
2021-01-15 5:49 pm |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | Hamilton James C Senior Vice President |
10,000 | $81.29 | $812,942 | 126,250 (Direct) |
View |
| 2021-01-11 Sale |
2021-01-12 6:06 pm |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | Myszkowski Kenneth Allen Chief Financial Officer |
13,038 | $81.02 | $1,056,310 | 444,005 (Direct) |
View |
| 2021-01-07 Sale |
2021-01-08 6:05 pm |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | Hassard James Chief Commercial Officer |
15,625 | $75 | $1,171,875 | 109,375 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-07-07 Exercise |
2022-07-11 8:08 pm |
2014-03-01 2024-02-06 |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | Anzalone Christopher Richard Chief Executive Officer |
2,501 | $0 | 4,672,667 (Direct) |
View |
| 2022-07-07 Exercise |
2022-07-11 8:08 pm |
N/A N/A |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | Anzalone Christopher Richard Chief Executive Officer |
2,501 | $14.54 | 4,672,667 (Direct) |
View |
Ownership |
2022-06-29 7:11 pm |
N/A N/A |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | Oliver Tracie Chief Commercial Officer |
0 | $0 | 70,000 (Direct) |
View |
Ownership |
2022-05-05 6:15 pm |
N/A N/A |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | Vakiener Victoria Director |
0 | $0 | 17,181 (Direct) |
View |
| 2022-02-11 Exercise |
2022-02-14 08:54 am |
2012-03-01 2022-02-16 |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | Anzalone Christopher Richard Chief Executive Officer |
146,388 | $0 | 4,672,667 (Direct) |
View |
| 2022-02-11 Exercise |
2022-02-14 08:54 am |
N/A N/A |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | Anzalone Christopher Richard Chief Executive Officer |
146,388 | $5.19 | 4,672,667 (Direct) |
View |
| 2022-01-07 Exercise |
2022-01-07 9:39 pm |
2012-03-01 2022-02-16 |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | Anzalone Christopher Richard Chief Executive Officer |
11,806 | $0 | 4,819,055 (Direct) |
View |
| 2022-01-07 Exercise |
2022-01-07 9:39 pm |
N/A N/A |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | Anzalone Christopher Richard Chief Executive Officer |
11,806 | $5.19 | 4,819,055 (Direct) |
View |
| 2020-12-04 Gift |
2022-01-07 8:16 pm |
N/A N/A |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | O'Brien Patrick General Counsel |
800 | $0 | 348,075 (Direct) |
View |
| 2022-01-07 Option Award |
2022-01-07 8:14 pm |
N/A N/A |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | Waddill William D. Director |
6,400 | $0 | 32,150 (Direct) |
View |
| 2022-01-07 Option Award |
2022-01-07 8:12 pm |
N/A N/A |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | PERRY MICHAEL S Director |
6,400 | $0 | 91,900 (Direct) |
View |
| 2022-01-07 Option Award |
2022-01-07 8:11 pm |
N/A N/A |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | OLUKOTUN ADEOYE Y Director |
6,400 | $0 | 11,350 (Direct) |
View |
| 2022-01-07 Option Award |
2022-01-07 8:10 pm |
N/A N/A |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | GIVEN DOUGLAS B Director |
6,400 | $0 | 142,643 (Direct) |
View |
| 2022-01-07 Option Award |
2022-01-07 8:08 pm |
N/A N/A |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | Ferrari Mauro Director |
6,400 | $0 | 42,971 (Direct) |
View |
| 2022-01-07 Option Award |
2022-01-07 8:07 pm |
N/A N/A |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | De Backer Marianne Director |
6,400 | $0 | 23,400 (Direct) |
View |
| 2022-01-01 Option Award |
2022-01-04 9:28 pm |
N/A N/A |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | Hamilton James C Senior Vice President |
55,000 | $0 | 181,250 (Direct) |
View |
| 2022-01-01 Option Award |
2022-01-04 9:26 pm |
N/A N/A |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | O'Brien Patrick General Counsel |
60,000 | $0 | 413,375 (Direct) |
View |
| 2021-12-31 Exercise |
2022-01-04 9:26 pm |
2016-02-01 2026-01-01 |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | O'Brien Patrick General Counsel |
28,000 | $0 | 413,375 (Direct) |
View |
| 2021-12-31 Exercise |
2022-01-04 9:26 pm |
N/A N/A |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | O'Brien Patrick General Counsel |
28,000 | $6.15 | 413,375 (Direct) |
View |
| 2022-01-01 Option Award |
2022-01-04 9:25 pm |
N/A N/A |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | Myszkowski Kenneth Allen Chief Financial Officer |
60,000 | $0 | 504,005 (Direct) |
View |
| 2022-01-01 Option Award |
2022-01-04 9:22 pm |
N/A N/A |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | Anzalone Christopher Richard Chief Executive Officer |
800,000 | $0 | 4,045,828 (Direct) |
View |
| 2021-12-28 Gift |
2021-12-29 8:44 pm |
N/A N/A |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | GIVEN DOUGLAS B Director |
655 | $0 | 136,243 (Direct) |
View |
| 2021-12-23 Exercise |
2021-12-23 9:52 pm |
2012-03-01 2022-02-16 |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | Anzalone Christopher Richard Chief Executive Officer |
11,806 | $0 | 4,019,055 (Direct) |
View |
| 2021-12-23 Exercise |
2021-12-23 9:52 pm |
N/A N/A |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | Anzalone Christopher Richard Chief Executive Officer |
11,806 | $5.19 | 4,019,055 (Direct) |
View |
| 2021-02-08 Exercise |
2021-02-10 5:56 pm |
N/A N/A |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | O'Brien Patrick General Counsel |
90,000 | $5.22 | 353,375 (Direct) |
View |
| 2021-02-08 Exercise |
2021-02-10 5:56 pm |
2015-06-02 2024-12-02 |
ARROWHEAD PHARMACEUTICALS INC. | ARWR | O'Brien Patrick General Counsel |
90,000 | $0 | 353,375 (Direct) |
View |